Interleukin Genetics (ILI) Announces $5.3M Registered Direct Offering; Expects $4.9M Net
Tweet Send to a Friend
Interleukin Genetics, Inc. (AMEX: ILI) today announced that it has received commitments from certain institutional investors to purchase approximately $5.3 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
